Hide Board Information

Show Board Information

JP Morgan Ch Cap X JPM-J

Board Mod: Add me as mod

Asst Mods:

Last Post: 10/29/2012 7:30:55 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

JP Morgan Ch Cap X (NYSE: JPM-J) Stock Message Board

1. JPM-J Company Profile

    

2. JPM-J Time & Sales

    

3. JPM-J Recent News

    

4. JPM-J Filings

    

5. JPM-J Financials

    

6. JPM-J Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on JP Morgan Ch Cap X JPM-J

Recent Articles

• Snap Inc. Investors: Important Class Action Update for You
• Investors Urged to Act Ahead of Secured Counsel Deadline
• C3.ai Faces Lawsuit: Investors Urged to Act Before Deadline
• Dow Inc. Faces Class Action: Important Info for Investors
• Important Legal Update for V.F. Corporation Shareholders
• Important Legal Update for Fluor Corporation Investors
• KBR Investor Alert: Key Actions and Important Updates
• Trump's Impact on Global Oil Dynamics and Peace Efforts
• Class Action Lawsuit Filed Against MoonLake Immunotherapeutics
• LifeMD, Inc. Class Action: Important Deadline Approaches
• Critical Update for Molina Healthcare, Inc. Investors – Act Now
• Democrats Seek Transparency on Google's Controversial Settlement
• Important Deadline Approaching for Tronox Holdings Investors
• Important Counsels for Nutex Health Investors Ahead of Deadline
• Cryptocurrencies Drop Amid Economic Uncertainty: Trends and Insights
• From Regret to Success: Garry Tan's $200 Million Lesson
• Transforming Industries with Edge AI: Primax and Vieureka's Vision
• Celebrating Eight Years of ChainUp: A Future in Crypto Growth
• The Future of Wireless EV Charging: Insights and Innovations
• KT&G Triumphs at the Prestigious PENTAWARDS 2025 Ceremony
• Kits Eyecare Limited Management Team Transition Announced
• Investors Eyeing Hims, Salesforce, Omeros, United Airlines, Sea
• Investors Encouraged to Join Larimar Therapeutics Inquiry
• Larimar Therapeutics Faces Legal Challenges Over Investor Claims
• KIC Ventures Leads the Way in Outpatient Spine Innovations
• Cathie Wood Makes Bold Moves in Chinese Tech Stocks
• Key Information for Telix Pharmaceuticals Ltd. Investors
• Andrea Pasqua Takes the Helm as Business Development Leader
• WPP Securities Class Action: Your Rights and Next Steps
• Pasqua Wines Cultivates New Legacy with Carole Bouquet
• Investors of Tandem Diabetes Care, Inc. Urged to Act Now
• FG Communities Expands Presence with Acquisition in Candler
• Graph AI Secures $3 Million Seed Funding to Innovate Safety Tech
• MoonLake Immunotherapeutics Faces Legal Challenges After Trial Failures
• CES Energy Solutions Corp. Secures $75 Million in Notes Offering
• Apollo Appoints Eiji Ueda as Head of Asia Pacific Division
• Investigation into Securities Violations: Your Rights Explained
• Blokees Unveils Exciting New Toys at Major Expo Event
• Exciting New Lines from Blokees at China Toy Expo 2025
• LXP Industrial Trust Offers Insightful Early Tender Results
• Explore the Rise of Visa Stock and What It Means Today
• How a $100 Investment in Applied Industrial Techs Grew Over Time
• Transforming $1000 into $14,566 in a Decade with MSTR
• Revolutionizing Data Centers: AMI and Fujitsu's New FUJITSU-MONAKA CPU
• Pioneering Breast Cancer Screening with AI and Innovation
• Codoxo Advances Healthcare Integrity with AI at NHCAA Conference
• Celebrating Excellence: PIH Health Good Samaritan's Recognition
• Flow Capital Declares Preferred Share Cash Dividend for Growth
• NGEx Minerals Achieves Milestone with C$175 Million Funding
• Key Developments in aTyr Pharma's Ongoing Securities Challenges